Alexandre Loupy

@KSusztak @GbadegesinLab bravo !

🚨 Our new paper just dropped !!! Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes nature.com/articles/s4159…

A new study identifies 7 distinct FEV1 trajectories post #LungTransplantation, each telling a different story of survival- should we consider personalized, trajectory-based monitoring of lung recipients? 🫁 @Raynaud_Maths, @drAntoineRoux, @AlexandreLoupy 🔗: jhltonline.org/article/S1053-…

@ChangUCanSpare 🦾

Just recently signed out the 10,000th kidney bx in my career. Only took 21 years

CONFIDENCE trial: In persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results and Research Summary: nej.md/4jEVbbk

@WashUNephrology @HumphreysLab @jclinicalinvest @WashUDeptMed Warm congratulations !

Congratulations to @HumphreysLab, Chief, @WashUNephrology, on joining the editorial board of @jclinicalinvest as Associate Editor! #Nephstrong @WashUDeptMed nephrology.wustl.edu/benjamin-humph…

@Tobias_B_Huber @PuellesVictor @UKEHamburg @AarhusUni @Nature Bravo !!!!

Hamburg News: ⁦@PuellesVictor⁩ and collaborators push tissue analytics to the next frontier. This also marks a remarkable academic path: from postdoc to junior professor in our group to full professor at ⁦@UKEHamburg⁩ & ⁦@AarhusUni⁩ ⁦@Nature⁩ nature.com/articles/s4158…

📢 Just out in @NatureComms & presented @ESOTtransplant ! Our study "Impact of HLA evolutionary divergence and molecular mismatches on AMR of kidney allografts" is now published. 🔗nature.com/articles/s4146… 🙌to @zpdemir2 Carmen Lefaucheur @AlexandreLoupy

🔬 A look at the top-tier journals in medicine and biomedical science interesting! congratulation on these top tier journals🚀🦾🚀🤩 •The Lancet IF: 98.4 •NEJM IF: 96.2 •The BMJ IF: 93.6 •Nature Medicine IF: 50.0 •JAMA IF: 50.0 •Nature IF: 48.5

From @ESOTtransplant #esotcongress 2025 2 amazing days working with colleagues on the @TheLancet commission. Paving the future of organ transplantation in the next 15 years !!!

📢 New publication in Xenotransplantation Journal by our group @ParisTxGroup @AlexandreLoupy ! Among the 2,900+ Xeno papers we assessed, 706 focused on solid organ & islet transplants from animals to humans 🐷➡️🧍 lnkd.in/eVKHzNVn Here’s a summary of what we found 👇

@VineetaKumar8 @amjtransplant @AST_info @AST_LDCOP well deserved !

From the Editorial Board of AJT 🙏🏼 @amjtransplant @AST_info @AST_LDCOP

@KristaLentine @CEOatNKF @nkf @NKF_NephPros @AST_info @RachelPatzerPhD @LorrindaD @ThePower2Save @slusom @SSMHealthSTL @WIT_TTS ❤️🚀🦾

In a field as complex as #transplantation, we can’t do it alone. #CEoT2025 reminded me how lucky we are to have colleagues who challenge, support & inspire each other🤝🏽 ·Collegiality makes the challenges feel lighter and the breakthroughs even bigger🚀 #donation | #transplant💙💚

@KristaLentine @AST_info @SumitMohanMD @EpiSnyder @beaukellymd @gracelyden @ThePower2Save @SSMHealthSTL @slusom @SRTRNews ❤️🚀

🙌🏾Honored to present ‘The Current State of #Data in Transplantation’🎤, #CEoT2025 Session 1 ‘What is the Future of Data to Drive Modernization?’ 🙏🏽Grateful to #PatientVoice panelist for setting stage: We must work together to gather data needed by patients, families➕clinicians📊

Thank you 🙏 for an amazing event and so many bright people ! go Mayo !

@SethiRenalPath @AnilaCara @GianMarcoB65728 🦾

Always a joy to teach and have company while signing out my Saturday morning cases. Anila & Gianmarco are among the most sincere & dedicated fellows I have met. Saw 9 cases ranging from ATN, lupus nephritis, IgA, diabetes, interstitial nephritis, membranous & myeloma kidney.